Gene · 974
Papers4,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 4,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Leprosy in a Patient With Lymphoma: A Challenge in the Twenty-First Century. | Cureus | 2023 | 38186457 | PubTator, text mining | PubMed |
| Clinical outcomes of newly diagnosed primary central nervous system lymphoma treated with zanubrutinib-based combination therapy. | World J Clin Oncol | 2023 | 38179402 | PubTator, text mining | PubMed |
| A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse. | J Hematop | 2023 | 38175437 | PubTator, text mining | PubMed |
| Key Cell Types and Biomarkers in Heart Failure Identified through Analysis of Single-Cell and Bulk RNA Sequencing Data. | Mediators Inflamm | 2023 | 38169915 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analyses inform necroptosis-associated myeloid lineages influence the immune landscape of pancreas cancer. | Front Immunol | 2023 | 38149248 | PubTator, text mining | PubMed |
| Unraveling the enigma of B cells in diffuse large B-cell lymphoma: unveiling cancer stem cell-like B cell subpopulation at single-cell resolution. | Front Immunol | 2023 | 38149239 | PubTator, text mining | PubMed |
| Immunologic barriers in liver transplantation: a single-cell analysis of the role of mesenchymal stem cells. | Front Immunol | 2023 | 38143768 | PubTator, text mining | PubMed |
| Special Issue: Evaluation of the Antitumor Mechanism of Armed Antibodies. | Pharmaceuticals (Basel) | 2023 | 38139816 | PubTator, text mining | PubMed |
| Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach. | Biomedicines | 2023 | 38137361 | PubTator, text mining | PubMed |
| Ibrutinib Plus RCHOP versus RCHOP Only in Young Patients with Activated B-Cell-like Diffuse Large B-Cell Lymphoma (ABC-DLBCL): A Cost-Effectiveness Analysis. | Curr Oncol | 2023 | 38132398 | PubTator, text mining | PubMed |
| Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma. | Curr Oncol | 2023 | 38132396 | PubTator, text mining | PubMed |
| Single-cell multi-omics analysis of human testicular germ cell tumor reveals its molecular features and microenvironment. | Nat Commun | 2023 | 38123589 | PubTator, text mining | PubMed |
| Hyperviscosity Syndrome Induced Bilateral Visual and Auditory Impairment in Therapy Resistant Waldenström Macroglobulinemia with MYD88 and CXCR4 Mutations. | J Blood Med | 2023 | 38116327 | PubTator, text mining | PubMed |
| Heterogeneity of tertiary lymphoid structures in cancer. | Front Immunol | 2023 | 38111571 | PubTator, text mining | PubMed |
| Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations. | Front Pharmacol | 2023 | 38108069 | PubTator, text mining | PubMed |
| Treatment for a primary multidrug-resistant B-cell acute lymphoblastic leukemia patient carrying a SSBP2-CSF1R fusion gene: a case report. | Front Oncol | 2023 | 38107066 | PubTator, text mining | PubMed |
| Identifying CD1c as a potential biomarker by the comprehensive exploration of tumor mutational burden and immune infiltration in diffuse large B cell lymphoma. | PeerJ | 2023 | 38099311 | PubTator, text mining | PubMed |
| The Simple prEservatioN of Single cElls method for cryopreservation enables the generation of single-cell immune profiles from whole blood. | Front Immunol | 2023 | 38090590 | PubTator, text mining | PubMed |
| Development of a contacting transwell co-culture system for the in vitro propagation of primary central nervous system lymphoma. | Front Cell Dev Biol | 2023 | 38089883 | PubTator, text mining | PubMed |
| Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned. | J Hematol Oncol | 2023 | 38087293 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/974/papers?page=18